These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9404936)

  • 41. Axoval neuropathy as initial manifestation of primary amyloidosis: report of a case submitted to bone marrow transplantation.
    Barsottini OG; Arantes A; Sigulem D; Kutner JM; Ribeiro AA; Moura LA; Hamerschlak N
    Arq Neuropsiquiatr; 2004 Sep; 62(3A):725-9. PubMed ID: 15334239
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tolerability and efficacy of thalidomide for the treatment of patients with light chain-associated (AL) amyloidosis.
    Seldin DC; Choufani EB; Dember LM; Wiesman JF; Berk JL; Falk RH; O'Hara C; Fennessey S; Finn KT; Wright DG; Skinner M; Sanchorawala V
    Clin Lymphoma; 2003 Mar; 3(4):241-6. PubMed ID: 12672274
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autologous stem cell transplantation in amyloidosis AL.
    Majolino I; Marceno R; Pecoraro G; Scime R; Vasta S; Liberti G; Rizzo A; Indovina A; Caronia F
    Bone Marrow Transplant; 1993 Jan; 11(1):85. PubMed ID: 8094310
    [No Abstract]   [Full Text] [Related]  

  • 44. Double autologous bone marrow transplantation and orthotopic liver transplantation in a patient with primary light chain (AL) amyloidosis.
    Binotto G; Cillo U; Trentin L; Piazza F; Zaninotto M; Semenzato G; Adami F
    Amyloid; 2011 Jun; 18 Suppl 1():132-4. PubMed ID: 21838461
    [No Abstract]   [Full Text] [Related]  

  • 45. Acute tumour lysis syndrome: a case in AL amyloidosis.
    Akasheh MS; Chang CP; Vesole DH
    Br J Haematol; 1999 Nov; 107(2):387. PubMed ID: 10583230
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Bone marrow transplantation in AL amyloidosis?].
    Winter EF
    Dtsch Med Wochenschr; 1991 Aug; 116(35):1334. PubMed ID: 1879331
    [No Abstract]   [Full Text] [Related]  

  • 47. Marked improvement by high-dose chemotherapy and autologous stem cell transplantation in a case of light chain deposition disease.
    Matsuzaki K; Ohsawa I; Nishitani T; Takeda Y; Inoshita H; Ishii M; Takagi M; Horikoshi S; Tomino Y
    J Nephrol; 2011; 24(2):246-9. PubMed ID: 21240874
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The radical treatment of paraprotein disorders affecting the kidney.
    Peniket AJ; Littlewood TJ; Winearls CG
    Nephrol Dial Transplant; 2003 Aug; 18(8):1431-4. PubMed ID: 12897075
    [No Abstract]   [Full Text] [Related]  

  • 49. Systemic mastocytosis accompanied by a non-secretory plasma cell dyscrasia and nephrotic syndrome-level proteinuria in a 76-year-old patient.
    Papadopoulou V; Ioannou S; Levidou G; Variami E; Kouzis P; Siakantaris M
    Acta Haematol; 2014; 131(2):78-83. PubMed ID: 24081151
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The return of the normal heart: resolution of cardiac amyloidosis after chemotherapy and bone marrow transplantation.
    Fitzgerald BT; Bashford J; Scalia GM
    Heart Lung Circ; 2013 Aug; 22(8):655-60. PubMed ID: 23474152
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amyloidosis: a changing clinical perspective.
    Jacobs P; Ruff P; Wood L; Moodley D; Mansvelt E
    Hematology; 2007 Apr; 12(2):163-7. PubMed ID: 17454199
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic myopathy due to immunoglobulin light chain amyloidosis.
    Manoli I; Kwan JY; Wang Q; Rushing EJ; Tsokos M; Arai AE; Burch WM; Dispenzieri A; McPherron AC; Gahl WA
    Mol Genet Metab; 2013 Apr; 108(4):249-54. PubMed ID: 23465863
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Systemic amyloidoses].
    Schönland S; Blank N; Kristen AV; Beimler J; Ganten T; Hegenbart U
    Internist (Berl); 2012 Jan; 53(1):51-64. PubMed ID: 22033913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of paraproteinemic renal disease.
    Sanders PW
    Curr Opin Nephrol Hypertens; 2005 Mar; 14(2):97-103. PubMed ID: 15687834
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study.
    Dispenzieri A; Kyle RA; Lacy MQ; Therneau TM; Larson DR; Plevak MF; Rajkumar SV; Fonseca R; Greipp PR; Witzig TE; Lust JA; Zeldenrust SR; Snow DS; Hayman SR; Litzow MR; Gastineau DA; Tefferi A; Inwards DJ; Micallef IN; Ansell SM; Porrata LF; Elliott MA; Gertz MA
    Blood; 2004 May; 103(10):3960-3. PubMed ID: 14739213
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amyloidosis with plasma cell dyscrasia. An overlooked caused of adult onset sensorimotor neuropathy.
    Trotter JL; Engel WK; Ignaczak FI
    Arch Neurol; 1977 Apr; 34(4):209-14. PubMed ID: 843255
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HLA antigens in amyloidosis associated with plasma cell dyscrasias (amyloid AL).
    Rubinow A; Cohen AS
    J Rheumatol; 1982; 9(6):942-3. PubMed ID: 7161785
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical remission after syngeneic bone marrow transplantation in a patient with AL amyloidosis.
    van Buren M; Hené RJ; Verdonck LF; Verzijlbergen FJ; Lokhorst HM
    Ann Intern Med; 1995 Apr; 122(7):508-10. PubMed ID: 7872585
    [No Abstract]   [Full Text] [Related]  

  • 59. Autologous Stem Cell Transplantation in the Treatment of Pulmonary Light Chain Deposition Disease.
    Rendo M; Franks TJ; Galvin JR; Berglund A; Volk C; Peterson M
    Chest; 2021 Jul; 160(1):e13-e17. PubMed ID: 34246382
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Plasma cell dyscrasia and amyloidosis].
    Isobe T; Yamauchi Y; Matsumoto J; Itoh T
    Nihon Rinsho; 1979 Sep; 37(9):3165-9. PubMed ID: 522263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.